CLINICAL TRIALS PROFILE FOR SANTYL
✉ Email this page to a colleague
All Clinical Trials for SANTYL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00651820 ↗ | Effect of Collagenase on Healing and Scarring | Completed | Healthpoint | Phase 4 | 2008-04-01 | A study to compare the rate of complete wound closure and quality of resulting scar at 3, 6 and 9 months, between dermatome-induced skin wounds treated with Collagenase Santyl Ointment versus vehicle alone. |
| NCT01056198 ↗ | Santyl vs. Sharp Debridement of Diabetic Foot Wounds | Completed | Healthpoint | Phase 4 | 2010-02-01 | This study tests two different approaches to the removal of dead tissue from the surface of a wound. |
| NCT01143714 ↗ | A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers | Completed | Healthpoint | Phase 4 | 2010-06-01 | The purpose of this study is to assess the effect of four weeks of treatment with Santyl Ointment, compared to White Petrolatum, on the change from baseline in wound area of diabetic foot ulcers over four weeks, and on the proportion of subjects achieving complete wound closure within 12 weeks from initiation of treatment. |
| NCT01143727 ↗ | Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers | Completed | Healthpoint | Phase 4 | 2010-07-01 | This study compares two standard methods for cleaning the surface of wounds on the feet of patients with diabetes mellitus. The question being asked is whether inflammation of the wound affects the ability of one or both of the methods to work. |
| NCT01516463 ↗ | Using Santyl or Bacitracin on Second Degree Burns | Withdrawn | Healthpoint | Phase 4 | 2012-03-01 | Subjects who have minor, second degree burns may be enrolled in this study. Subjects will receive either Santyl ointment or bacitracin ointment to apply to the burn until it heals. Bandages will be used to keep the burn covered while it heals. Second degree burns generally leave a scar. Once the burn heals, lotion and an appropriate bandage will be used to try to minimize the appearance of a scar. The study hypothesis is that burns treated with Santyl will have a better scar appearance than burns treated with bacitracin. Subjects enrolled in this study will make once a week visits to the University of Kansas Medical Center outpatient burn clinic until the burn heals. The burn will be assessed for healing at these visits. Once healed, visits to the clinic will be every 1-3 months for up to 1 year. At these visits, the appearance of the scar will be evaluated |
| NCT02131961 ↗ | EZCast-DFU Study With Portal for Application of Topical Medications | Completed | University of Miami | Phase 1 | 2014-10-01 | This study is designed to evaluate the ability to modify a contact cast system so that topical medications can be applied daily to an underlying wound in patients with diabetic plantar ulcers. The modification of the cast will be done by making an opening where the wound is located in the contact cast system. A contact cast system is a device that will reduce the pressure in the area where the wound is located. |
| NCT02482948 ↗ | MEDIHONEY® Gel Versus Collagenase for Wound Debridement | Terminated | Derma Sciences, Inc. | N/A | 2015-06-01 | The purpose of this study is to compare how well two products, Active Leptospermum Honey (ALH) (MEDIHONEY® Gel) and Collagenase (Santyl®), in removing the nonviable (non living) tissue. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SANTYL
Condition Name
Clinical Trial Locations for SANTYL
Trials by Country
Clinical Trial Progress for SANTYL
Clinical Trial Phase
Clinical Trial Sponsors for SANTYL
Sponsor Name
